Shemesh Shay 4
4 · Nuvectis Pharma, Inc. · Filed May 18, 2022
Insider Transaction Report
Form 4
Shemesh Shay
Chief Dev. & Ops. Officer
Transactions
- Purchase
Common Stock
2022-05-16$19.28/sh+100$1,928→ 1,240,993 total - Purchase
Common Stock
2022-05-17$19.55/sh+142$2,776→ 1,241,135 total
Footnotes (2)
- [F1]Includes 48,399 shares of restricted stock and 60,000 restricted stock units.
- [F2]Reflects the weighted average purchase price. The range of prices for the shares purchased was $19.23 to $19.94. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.